Vasculogenic ED Through the Lens of the AUA Guideline: Arterial vs. Venous Causes

When a clinician describes erectile dysfunction as "vascular," the term covers two distinct mechanical problems. One is inadequate blood flow into the penis. The other is inadequate retention of blood once it arrives. The two can produce similar symptoms and frequently occur together, but they respond to different treatments.

The 2018 American Urological Association (AUA) Erectile Dysfunction Guideline treats this distinction as clinically significant, and its recommendations for the two conditions differ substantially.

This article is the fourth in our series on the AUA Erectile Dysfunction Guideline. The first explained what the guideline is, the second covered venous leak and surgery, and the third examined shared decision-making. This article covers how arterial and venous causes are distinguished, and what that distinction means for treatment selection.

Background: what the AUA Guideline is

The Erectile Dysfunction: AUA Guideline (2018) is the primary evidence-based document guiding how urologists in the United States evaluate and treat ED. Its statements carry designations such as Strong, Moderate, or Conditional Recommendation, or are labeled Clinical Principle or Expert Opinion where professional consensus exceeds the available evidence. For a fuller overview, see our earlier article on the guideline itself.

The two mechanisms

An erection requires adequate blood flow into the penis and adequate resistance to blood flowing back out.

Arteriogenic ED: reduced inflow

The cavernosal arteries supply blood to the erectile tissue. When these arteries are narrowed or damaged by atherosclerosis, diabetes, hypertension, smoking, or pelvic injury, insufficient blood arrives to produce firmness. This is arteriogenic, or arterial, ED. The typical presentation is difficulty achieving an erection, or achieving only a partial one.

Venogenic ED: excessive outflow

As the erectile chambers fill, the expanding tissue compresses the veins against the tunica albuginea, restricting outflow. When this mechanism fails, blood drains as quickly as it arrives. This is venogenic ED, also called veno-occlusive dysfunction (VOD) or corporoveno-occlusive dysfunction (CVOD), and commonly known as venous leak. The typical presentation differs: an erection that begins adequately and then diminishes, often within minutes, or one that is lost on changing position.

Our guide to venous leak and erectile dysfunction covers the mechanism and its symptoms in more detail.

Why both mechanisms are often present

These categories overlap. The conditions that damage arteries also affect the smooth muscle and connective tissue on which the veno-occlusive mechanism depends. Diabetes is a clear example: it impairs the ability of erectile smooth muscle to relax, which compromises both filling and sealing. Aging has a comparable effect, reducing the firmness available to compress the veins while stiffening the vessels requiring compression.

For this reason, the clinically useful question is usually which mechanism predominates and how much each contributes, rather than which one is present.

How the distinction is made

The guideline's evaluation statements establish the baseline. Statement 1 is a Clinical Principle: men presenting with ED should undergo a thorough medical, sexual, and psychosocial history, a physical examination, and selective laboratory testing. Statement 4 (Moderate Recommendation; Evidence Level: Grade C) adds that morning serum total testosterone should be measured, since hormonal factors can mimic or compound vascular ones.

Statement 5 is framed permissively: for some men with ED, specialized testing and evaluation may be necessary to guide treatment (Expert Opinion). It refers to "some men" rather than all men because for the majority, treatment selection does not depend on precise hemodynamic classification.

Where specialized testing is indicated, penile duplex Doppler ultrasound is the standard investigation. A vasoactive drug is injected to induce an erection and ultrasound measures blood flow in the cavernosal arteries. Reduced arterial inflow indicates an arterial cause. Adequate inflow combined with persistently elevated end-diastolic flow, indicating continued venous drainage, points toward veno-occlusive dysfunction. The test is painless and takes under an hour.

The test has recognized limitations. An initial diagnosis of venous leak on Doppler ultrasound is not always confirmed on repeat testing. Teloken et al. (2011) found that a substantial proportion of men previously labeled with venous leak showed normal or different hemodynamics on re-evaluation. Anxiety during the procedure can constrict blood flow and produce findings resembling arterial insufficiency. Examiner experience affects reliability.

How the guideline treats the two conditions

The guideline's two surgical statements reach opposite conclusions, which indicates how significant the panel considered this distinction.

Statement 21 (Conditional Recommendation; Evidence Level: Grade C) states that for young men with ED and focal pelvic or penile arterial occlusion, and without documented generalized vascular disease or veno-occlusive dysfunction, penile arterial reconstruction may be considered. The indication is narrow, and the presence of veno-occlusive dysfunction is an explicit exclusion, since restoring inflow provides limited benefit when retention is impaired.

Statement 22 (Moderate Recommendation; Evidence Level: Grade C) states that for men with ED, penile venous surgery is not recommended. The panel reviewed approximately 3,000 men across dozens of study arms and identified highly variable patient selection, diverse surgical techniques, short follow-up periods, and durable success rates that declined over time. This is covered in detail in the second article in this series.

The guideline therefore permits a narrowly defined surgical option for arterial disease in young men, while not recommending surgery for venous disease.

What the distinction means for treatment

Most ED treatments act primarily on one side of the mechanism.

Primarily addressing inflow: oral PDE5 inhibitors, intracavernosal injections, intraurethral alprostadil, and vacuum erection devices increase blood flow into the penis.

Primarily addressing outflow: constriction devices worn at the base of the penis slow the drainage of blood that has already arrived. Pelvic floor training works by a related mechanism, strengthening the muscles that assist venous compression.

This accounts for a pattern many men report. If treatments that increase inflow produce a partial or short-lived result, the explanation may be that inflow was not the limiting factor. Increasing inflow does not correct impaired retention.

It also accounts for the use of combination approaches when both mechanisms are involved: one treatment to support inflow, another to slow outflow. Under the guideline's shared decision-making framework, discussed in our previous article, beginning with a combination rather than sequential single treatments is a legitimate option.

If you use a constriction device, observe the standard safe-use limits: a maximum of 30 minutes of continuous wear, removal before sleeping, and immediate removal if numbness, coldness, discolouration, or pain occurs. Men taking anticoagulants, men with sickle cell disease, and men with reduced penile sensation should consult a physician before use.

Vascular ED as a cardiovascular marker

Statement 3 is a Clinical Principle: men should be counseled that ED is a risk marker for underlying cardiovascular disease and other health conditions that may warrant evaluation and treatment.

The penile arteries are small in calibre. When systemic vascular disease develops, these vessels are often affected before the coronary arteries, in some cases by several years.

Vasculogenic ED of either type is therefore a general health finding as well as a sexual one. If your evaluation indicates a vascular cause, cardiovascular risk assessment is appropriate.

Practical points

• Ask whether your evaluation indicates an inflow problem, an outflow problem, or both. "Vascular" alone is not a complete answer.
• Describe your symptom pattern precisely. Difficulty achieving an erection indicates a different mechanism from difficulty maintaining one, or loss of firmness on changing position.
• If inflow-focused treatments have produced weak or short-lived results, raise the possibility that outflow is the dominant problem.
• Ask whether specialized testing would change your treatment plan. In many cases it would not.
• Treat a vascular finding as an indication to assess your broader cardiovascular health.

Summary

• Vasculogenic ED comprises arteriogenic (reduced inflow) and venogenic or veno-occlusive (excessive outflow) causes. Many men have both.
• The guideline's evaluation statements call for thorough history, examination, and selective laboratory testing (Statement 1) and morning testosterone measurement (Statement 4). Specialized testing is reserved for men in whom it would change management (Statement 5).
• Penile duplex Doppler ultrasound is the standard method of distinguishing the two, with recognized limitations in reliability.
• The guideline permits penile arterial reconstruction only for young men with focal arterial occlusion and excludes those with veno-occlusive dysfunction (Statement 21), and does not recommend penile venous surgery (Statement 22).
• Most treatments act mainly on inflow. Approaches that improve blood retention act on outflow. Which mechanism predominates should inform treatment selection, whether single or combined.
• ED of vascular origin is a recognized early marker of cardiovascular disease (Statement 3).

The final article in this series examines the full range of treatment options presented in the 2018 guideline, and the approaches available to men whose primary problem is retention.

References

• Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. Journal of Urology. 2018;200(3):633–641. https://www.auajournals.org/doi/10.1016/j.juro.2018.05.004
• American Urological Association. Erectile Dysfunction: AUA Guideline (2018) — unabridged version, including Statements 1, 3, 4 and 5 on evaluation and Statements 21 and 22 on penile arterial reconstruction and venous surgery. AUA Guidelines page
• Teloken PE, et al. The False Diagnosis of Venous Leak: Prevalence and Predictors. Journal of Sexual Medicine. 2011.
• Hoppe H, et al. Percutaneous Treatment of Venous Erectile Dysfunction. Frontiers in Cardiovascular Medicine. 2021. https://www.frontiersin.org/articles/10.3389/fcvm.2020.626943/full